Losigamone
Losigamone is an antiepileptic drug that was developed for the treatment of epilepsy, a neurological disorder characterized by recurrent seizures. It is a member of the class of drugs known as gamma-aminobutyric acid (GABA) enhancers, which work by increasing the activity of GABA, a neurotransmitter in the brain that inhibits the firing of neurons and thus helps to prevent seizures.
History[edit]
Losigamone was first synthesized in the late 1980s by the German pharmaceutical company Schwarz Pharma. It was initially developed as a potential treatment for epilepsy, but its development was discontinued in the late 1990s due to concerns about its safety and efficacy.
Mechanism of Action[edit]
Losigamone works by enhancing the activity of GABA, a neurotransmitter that inhibits the firing of neurons in the brain. It does this by binding to a specific site on the GABA receptor, which increases the receptor's sensitivity to GABA. This increased sensitivity results in an increased inhibitory effect on neuronal firing, which can help to prevent seizures.
Clinical Trials[edit]
Several clinical trials were conducted in the 1990s to evaluate the safety and efficacy of losigamone in patients with epilepsy. These trials showed that losigamone was effective in reducing the frequency of seizures in some patients. However, the drug was also associated with a number of side effects, including dizziness, fatigue, and weight gain. These side effects, combined with concerns about the drug's long-term safety, led to the decision to discontinue its development.
Current Status[edit]
As of 2021, losigamone is not approved for use in any country. However, research into its potential uses continues. Some studies have suggested that it may have potential as a treatment for other neurological disorders, such as Parkinson's disease and Huntington's disease, but further research is needed to confirm these findings.
See Also[edit]
-
Skeletal structure of Losigamone
-
3D ball model of Losigamone
Ad. Transform your life with W8MD's Budget GLP-1 injections from $75


W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Weight loss injections in NYC (generic and brand names):
- Zepbound / Mounjaro, Wegovy / Ozempic, Saxenda
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $75 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointmentsNYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
